title: Consensus guidelines for reporting prostate cancer Gleason Grade.
authors.affiliation: Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden. lars.egevad@ki.se.
authors.forename: Lars
authors.initials: L
authors.lastname: Egevad
authors.affiliation: Department of Pathology, University of Queensland and Aquesta Uropathology, Brisbane, QLD, Australia.
authors.forename: Hemamali
authors.initials: H
authors.lastname: Samaratunga
authors.affiliation: Department of Pathology and Molecular Medicine, McMaster University, Toronto, ON, Canada.
authors.forename: John R
authors.initials: JR
authors.lastname: Srigley
authors.affiliation: Professor of Pathology and Molecular Medicine, Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand.
authors.forename: Brett
authors.initials: B
authors.lastname: Delahunt
authors.forename: Anthony
authors.initials: A
authors.lastname: Zietman
authors.forename: Joseph
authors.initials: J
authors.lastname: Smith
authors.forename: Eric
authors.initials: E
authors.lastname: Klein
authors.forename: Michael
authors.initials: M
authors.lastname: Droller
authors.forename: Prokar
authors.initials: P
authors.lastname: Dasgupta
authors.forename: James
authors.initials: J
authors.lastname: Catto
mesh_terms: D032921:Consensus; D006801:Humans; D008297:Male; D060787:Neoplasm Grading; D017430:Prostate-Specific Antigen; D011471:Prostatic Neoplasms
chemical_list: D017430:Prostate-Specific Antigen